Priit Kogerman

2.3k total citations
31 papers, 1.8k citations indexed

About

Priit Kogerman is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, Priit Kogerman has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Cell Biology. Recurrent topics in Priit Kogerman's work include Hedgehog Signaling Pathway Studies (17 papers), Proteoglycans and glycosaminoglycans research (9 papers) and Epigenetics and DNA Methylation (6 papers). Priit Kogerman is often cited by papers focused on Hedgehog Signaling Pathway Studies (17 papers), Proteoglycans and glycosaminoglycans research (9 papers) and Epigenetics and DNA Methylation (6 papers). Priit Kogerman collaborates with scholars based in Estonia, United States and Sweden. Priit Kogerman's co-authors include Rune Toftgård, Torben Østerlund, Peter G. Zaphiropoulos, Darren Krause, Bengt Sandstedt, Thomas W. Grimm, Marina Dunaeva, Marika Kleman, Lloyd A. Culp and Leslie G. Biesecker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Priit Kogerman

30 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priit Kogerman Estonia 20 1.6k 556 231 151 115 31 1.8k
Gerhard Regl Austria 16 1.5k 0.9× 332 0.6× 482 2.1× 66 0.4× 89 0.8× 19 1.8k
Scott X. Atwood United States 20 1.6k 1.0× 388 0.7× 315 1.4× 418 2.8× 119 1.0× 39 2.0k
W J Van de Ven Belgium 26 1.1k 0.7× 515 0.9× 366 1.6× 422 2.8× 180 1.6× 37 2.0k
Monica Peacocke United States 24 1.3k 0.8× 445 0.8× 292 1.3× 478 3.2× 147 1.3× 54 2.2k
Johanna Pispa Finland 22 2.0k 1.3× 271 0.5× 136 0.6× 447 3.0× 164 1.4× 32 2.5k
Mark Wijgerde Netherlands 17 1.9k 1.2× 514 0.9× 108 0.5× 156 1.0× 97 0.8× 21 2.1k
Michael Naso United States 14 1.1k 0.7× 556 1.0× 290 1.3× 285 1.9× 109 0.9× 28 1.8k
Luisa Izzi Canada 14 978 0.6× 196 0.4× 237 1.0× 83 0.5× 73 0.6× 18 1.3k
Jeong Kyo Yoon United States 28 1.9k 1.2× 489 0.9× 289 1.3× 232 1.5× 198 1.7× 43 2.3k
Virginie Clément France 15 1.7k 1.1× 426 0.8× 932 4.0× 112 0.7× 452 3.9× 23 2.4k

Countries citing papers authored by Priit Kogerman

Since Specialization
Citations

This map shows the geographic impact of Priit Kogerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priit Kogerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priit Kogerman more than expected).

Fields of papers citing papers by Priit Kogerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priit Kogerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priit Kogerman. The network helps show where Priit Kogerman may publish in the future.

Co-authorship network of co-authors of Priit Kogerman

This figure shows the co-authorship network connecting the top 25 collaborators of Priit Kogerman. A scholar is included among the top collaborators of Priit Kogerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priit Kogerman. Priit Kogerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vanatalu, Kalju, et al.. (2013). The Transcriptional Repressor Domain of Gli3 Is Intrinsically Disordered. PLoS ONE. 8(10). e76972–e76972. 5 indexed citations
2.
Kasak, Lagle, et al.. (2011). Soluble CD44 Interacts with Intermediate Filament Protein Vimentin on Endothelial Cell Surface. PLoS ONE. 6(12). e29305–e29305. 59 indexed citations
3.
Kulp, Maria, Olga Bragina, Priit Kogerman, & Mihkel Kaljurand. (2011). Capillary electrophoresis with led-induced native fluorescence detection for determination of isoquinoline alkaloids and their cytotoxicity in extracts of Chelidonium majus L. Journal of Chromatography A. 1218(31). 5298–5304. 39 indexed citations
4.
Bragina, Olga, et al.. (2010). Smoothened agonist augments proliferation and survival of neural cells. Neuroscience Letters. 482(2). 81–85. 31 indexed citations
5.
Bragina, Olga, et al.. (2010). Sonic Hedgehog pathway activity in prostate cancer. Oncology Letters. 1(2). 319–325. 10 indexed citations
6.
Piirsoo, Marko, et al.. (2009). Identification of a novel serine/threonine kinase ULK3 as a positive regulator of Hedgehog pathway. Experimental Cell Research. 316(4). 627–637. 64 indexed citations
7.
Metsis, Madis, et al.. (2008). Identification of the gene transcription repressor domain of Gli3. FEBS Letters. 583(1). 224–228. 27 indexed citations
9.
Finta, Csaba, et al.. (2007). A possible role of mouse Fused (STK36) in Hedgehog signaling and Gli transcription factor regulation. Journal of Cell Communication and Signaling. 1(3-4). 165–173. 15 indexed citations
10.
Østerlund, Torben & Priit Kogerman. (2006). Hedgehog signalling: how to get from Smo to Ci and Gli. Trends in Cell Biology. 16(4). 176–180. 100 indexed citations
11.
Trummal, Katrin, Külli Tõnismägi, Ene Siigur, et al.. (2005). A novel metalloprotease from Vipera lebetina venom induces human endothelial cell apoptosis. Toxicon. 46(1). 46–61. 65 indexed citations
12.
Andaloussi, Samir EL, Peter Järver, Andres Valkna, et al.. (2005). Evaluation of transportan 10 in PEI mediated plasmid delivery assay. Journal of Controlled Release. 103(2). 511–523. 63 indexed citations
14.
15.
Regamey, Alexandre, Daniel Hohl, Jia Wei Liu, et al.. (2003). The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor. The Journal of Experimental Medicine. 198(12). 1959–1964. 96 indexed citations
16.
Dunaeva, Marina, et al.. (2003). Characterization of the Physical Interaction of Gli Proteins with SUFU Proteins. Journal of Biological Chemistry. 278(7). 5116–5122. 149 indexed citations
17.
Kogerman, Priit, Darren Krause, Fahimeh Rahnama, et al.. (2002). Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein. Oncogene. 21(39). 6007–6016. 58 indexed citations
18.
Kogerman, Priit, Man‐Sun Sy, & Lloyd A. Culp. (1997). Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model. Oncogene. 15(12). 1407–1416. 20 indexed citations
19.
Kogerman, Priit, Man‐Sun Sy, & Lloyd A. Culp. (1996). Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence. Clinical & Experimental Metastasis. 14(1). 73–82. 14 indexed citations
20.
Kogerman, Priit, Man‐Sun Sy, & Lloyd A. Culp. (1996). CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with theras but not with thesis Oncogene. Journal of Cellular Physiology. 169(2). 341–349. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026